Publikationen von Felix Bröcker
Alle Typen
Zeitschriftenartikel (23)
1.
Zeitschriftenartikel
213 (4), 107795 (2021)
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2. Journal of Structural Biology 2.
Zeitschriftenartikel
95 (23), e01249-21 (2021)
Structural study of AAVrh.10 receptor and antibody interactions. Journal of Virology 3.
Zeitschriftenartikel
11, 2694 (2020)
Glycan-dependent cell adhesion mechanism of Tc toxins. Nature Communications 4.
Zeitschriftenartikel
14 (12), S. 2720 - 2728 (2019)
Synthetic oligosaccharide-based vaccines protect mice from clostridioides difficile infections. ACS Chemical Biology 5.
Zeitschriftenartikel
61 (11), S. 4918 - 4927 (2018)
Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-α-GalCer vaccine candidate. Journal of Medicinal Chemistry 6.
Zeitschriftenartikel
597, S. 311 - 334 (2017)
Identification and design of synthetic B cell epitopes for carbohydrate-based vaccines. Methods in Enzymology 7.
Zeitschriftenartikel
2 (1), S. 114 - 124 (2017)
Automated glycan assembly of oligo-N-acetyllactosamine and keratan sulfate probes to study virus-glycan interactions. Chem 8.
Zeitschriftenartikel
7, 25 (2016)
The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation. Mobile DNA 9.
Zeitschriftenartikel
2 (1), a000448 (2016)
Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Cold Spring Harbor Molecular Case Studies 10.
Zeitschriftenartikel
23 (8), S. 1014 - 1022 (2016)
Synthetic lipoteichoic acid glycans are potential vaccine candidates to protect from Clostridium difficile infections. Cell Chemical Biology 11.
Zeitschriftenartikel
7, 11224 (2016)
Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nature Communications 12.
Zeitschriftenartikel
1372 (1), S. 29 - 41 (2016)
Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection. Annals of the New York Academy of Sciences 13.
Zeitschriftenartikel
6, 20488 (2016)
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports 14.
Zeitschriftenartikel
6 (4), e1251380 (2016)
Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases. Bacteriophage 15.
Zeitschriftenartikel
1341 (1), S. 126 - 135 (2015)
The reverse transcriptase-RNase H: from viruses to antiviral defense. Annals of the New York Academy of Sciences 16.
Zeitschriftenartikel
9 (4), S. 867 - 873 (2014)
Epitope recognition of antibodies against a Yersinia pestis lipopolysaccharide trisaccharide component. ACS Chemical Biology 17.
Zeitschriftenartikel
88 (5), S. 2991 - 3003 (2014)
Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans. Journal of Virology 18.
Zeitschriftenartikel
24 (1), S. 1 - 11 (2014)
Generation and analysis of draft sequences of 'Stolbur' phytoplasma from multiple displacement amplification templates. Journal of Molecular Microbiology and Biotechnology 19.
Zeitschriftenartikel
71 (14), S. 2717 - 2729 (2014)
The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides. Cellular and Molecular Life Sciences 20.
Zeitschriftenartikel
88 (4), S. 243 - 251 (2013)
Analysis of the Intestinal Microbiome of a Recovered Clostridium difficile Patient after Fecal Transplantation. Digestion